Amerise Biosciences Intrinsic Value

Amerise Biosciences (AMERISE) median intrinsic value is ₹1.77 from 1 valuation models (range ₹2–₹2), vs current price ₹0.71 — +149.3% upside (Trading Below Calculated Value), margin of safety 59.9%. Browse Amerise Biosciences financial data for revenue, profit, balance sheet and cash flow data.

Current Stock Price
₹0.71
Primary Intrinsic Value
₹1.77
Market Cap
₹0.5 Cr
+149.3% Upside
Median Value
₹1.77
Value Range
₹2 - ₹2
Assessment
Trading Below Calculated Value
Safety Margin
59.9%

AMERISE Valuation Methods Summary — DCF, Graham Number & P/E

Amerise Biosciences intrinsic value across 1 models vs current price ₹0.71 — upside/downside and value range per method. Also explore AMERISE price movement history to track price trends across different timeframes.

Method Type Intrinsic Value Range Upside/Downside Details
Book Value Method asset ₹1.77 ₹1.59 - ₹1.95 +149.3% Book Value/Share: ₹7.14, P/B: 1.0x
Method Types: Earnings Asset DCF Growth Dividend Conservative

AMERISE Intrinsic Value vs Market Price — All Valuation Models

Amerise Biosciences fair value range ₹2–₹2 vs current market price ₹0.71 across 1 valuation models. For current market price and key ratios, visit AMERISE stock price BSE.

AMERISE Intrinsic Value Analysis — Undervalued or Overvalued?

Amerise Biosciences median intrinsic value ₹1.77, current price ₹0.71 — Trading Below Calculated Value by 149.3%, margin of safety 59.9%.

What is the intrinsic value of AMERISE?

Based on our comprehensive analysis using 1 different valuation methods, the estimated intrinsic value of Amerise Biosciences (AMERISE) is ₹1.77 (median value). With the current market price of ₹0.71, this represents a +149.3% variance from our estimated fair value.

The valuation range spans from ₹1.77 to ₹1.77, indicating ₹1.77 - ₹1.77.

Is AMERISE undervalued or overvalued?

Based on our multi-method analysis, Amerise Biosciences (AMERISE) appears to be trading below calculated value by approximately 149.3%.

AMERISE Cash Flow Quality — Operating & Free Cash Flow

Amerise Biosciences operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹3 Cr ₹2 Cr Positive Free Cash Flow 7/10
March 2024 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2023 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2022 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2021 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10